These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32151994)

  • 1. Elevated IL18 levels in Nasopharyngeal carcinoma induced PD-1 expression on NK cells in TILS leading to poor prognosis.
    Liou AK; Soon G; Tan L; Peng Y; Cher BM; Goh BC; Wang S; Lim CM
    Oral Oncol; 2020 May; 104():104616. PubMed ID: 32151994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
    Larbcharoensub N; Mahaprom K; Jiarpinitnun C; Trachu N; Tubthong N; Pattaranutaporn P; Sirachainan E; Ngamphaiboon N
    Am J Clin Oncol; 2018 Dec; 41(12):1204-1210. PubMed ID: 29672367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
    Ahmed MM; Gebriel MG; Morad EA; Saber IM; Elwan A; Salah M; Fakhr AE; Shalaby AM; Alabiad MA
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):401-408. PubMed ID: 33480605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.
    Lu J; Chen XM; Huang HR; Zhao FP; Wang F; Liu X; Li XP
    Head Neck; 2018 Jun; 40(6):1245-1253. PubMed ID: 29493822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma.
    Jiang F; Yu W; Zeng F; Cheng G; Xu J; Yang S; Shui Y; Wu D; Yu XF; Wei Q
    BMC Cancer; 2019 May; 19(1):503. PubMed ID: 31138162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study.
    Wang YQ; Chen YP; Zhang Y; Jiang W; Liu N; Yun JP; Sun Y; He QM; Tang XR; Wen X; Yang XJ; Zhang PP; Zhang J; Lei Y; Li YQ; Ma J
    Int J Cancer; 2018 Jun; 142(12):2558-2566. PubMed ID: 29377121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy Combined with PD-1 Inhibition Increases NK Cell Cytotoxicity towards Nasopharyngeal Carcinoma Cells.
    Makowska A; Lelabi N; Nothbaum C; Shen L; Busson P; Tran TTB; Eble M; Kontny U
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1.
    Makowska A; Meier S; Shen L; Busson P; Baloche V; Kontny U
    Cancer Immunol Immunother; 2021 Feb; 70(2):323-336. PubMed ID: 32737537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.
    Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I
    Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
    Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
    JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load.
    Zhou Y; Shi D; Miao J; Wu H; Chen J; Zhou X; Hu D; Zhao C; Deng W; Xie C
    Sci Rep; 2017 Mar; 7():43627. PubMed ID: 28256540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis.
    Berele BA; Cai Y; Yang G
    Technol Cancer Res Treat; 2021; 20():15330338211034265. PubMed ID: 34323154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg JA; Braunius WW; Zuur CI; Koljenović S; Willems SM
    Oral Oncol; 2017 Aug; 71():16-25. PubMed ID: 28688685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma.
    Zhang J; Fang W; Qin T; Yang Y; Hong S; Liang W; Ma Y; Zhao H; Huang Y; Xue C; Huang P; Hu Z; Zhao Y; Zhang L
    Med Oncol; 2015 Mar; 32(3):86. PubMed ID: 25702326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Infiltrating Lymphocytes as an Independent Prognostic Factor in Undifferentiated Nasopharyngeal Carcinoma.
    Febriani V; Indrawati I; Sumpono ASB; Ferronika P; Bawono RG; Dwianingsih EK
    Asian Pac J Cancer Prev; 2024 Jun; 25(6):1997-2002. PubMed ID: 38918661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.
    Luo F; Cao J; Lu F; Zeng K; Ma W; Huang Y; Zhang L; Zhao H
    Cancer Cell Int; 2021 Aug; 21(1):458. PubMed ID: 34454491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV-Upregulated B7-H3 Inhibits NK cell-Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression.
    Chen H; Duan X; Deng X; Huang Y; Zhou X; Zhang S; Zhang X; Liu P; Yang C; Liu G; Ren Q; Xiong Y; Zhu B; Zhang J; Xiang T
    Cancer Immunol Res; 2023 Jun; 11(6):830-846. PubMed ID: 36996321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
    Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
    Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma.
    Lv L; Pan K; Li XD; She KL; Zhao JJ; Wang W; Chen JG; Chen YB; Yun JP; Xia JC
    PLoS One; 2011 Mar; 6(3):e18219. PubMed ID: 21483813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.